TY  - GEN
AU  - Hsu,Fei-Ting
AU  - Liu,Yu-Chang
AU  - Chiang,I-Tsang
AU  - Liu,Ren-Shyan
AU  - Wang,Hsin-Ell
AU  - Lin,Wuu-Jyh
AU  - Hwang,Jeng-Jong
TI  - Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling
SN  - 1791-2423
PY  - 2015///0115
KW  - Animals
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Carcinoma, Hepatocellular
KW  - pathology
KW  - Cell Line, Tumor
KW  - Drug Synergism
KW  - Humans
KW  - Hydroxamic Acids
KW  - Liver Neoplasms
KW  - Liver Neoplasms, Experimental
KW  - MAP Kinase Signaling System
KW  - drug effects
KW  - Male
KW  - Mice
KW  - Mice, Nude
KW  - Niacinamide
KW  - Phenylurea Compounds
KW  - Protein Serine-Threonine Kinases
KW  - metabolism
KW  - Sorafenib
KW  - Vorinostat
KW  - Xenograft Model Antitumor Assays
KW  - NF-kappaB-Inducing Kinase
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3892/ijo.2014.2423
ER  -